Embecta Corp (EMBC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Embecta Corp (EMBC) has a cash flow conversion efficiency ratio of -0.050x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($31.10 Million) by net assets ($-626.10 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See EMBC equity to assets ratio to measure how much of total assets are equity-financed.
Embecta Corp - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Embecta Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Embecta Corp (EMBC) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Embecta Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Embecta Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sidus Space Inc
NASDAQ:SIDU
|
-0.119x |
|
Staude Capital Global Value Fund Ltd
AU:GVF
|
-0.035x |
|
Stic Investments Inc
KO:026890
|
0.005x |
|
Vuzix Corp Cmn Stk
NASDAQ:VUZI
|
-0.163x |
|
Can2 Termik AS
IS:CANTE
|
0.020x |
|
Volati AB
ST:VOLO
|
-0.060x |
|
Canaan Inc
NASDAQ:CAN
|
-0.569x |
|
PAMT CORP
NASDAQ:PAMT
|
-0.028x |
Annual Cash Flow Conversion Efficiency for Embecta Corp (2019–2025)
The table below shows the annual cash flow conversion efficiency of Embecta Corp from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see Embecta Corp market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $-651.20 Million | $191.70 Million | -0.294x | -508.80% |
| 2024-09-30 | $-738.30 Million | $35.70 Million | -0.048x | +41.31% |
| 2023-09-30 | $-821.70 Million | $67.70 Million | -0.082x | +82.18% |
| 2022-09-30 | $-891.40 Million | $412.20 Million | -0.462x | -160.24% |
| 2021-09-30 | $594.00 Million | $456.00 Million | 0.768x | -11.91% |
| 2020-09-30 | $572.00 Million | $498.50 Million | 0.872x | +6.82% |
| 2019-09-30 | $619.00 Million | $505.00 Million | 0.816x | -- |
About Embecta Corp
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors… Read more